179 related articles for article (PubMed ID: 10051623)
1. Terreic acid, a quinone epoxide inhibitor of Bruton's tyrosine kinase.
Kawakami Y; Hartman SE; Kinoshita E; Suzuki H; Kitaura J; Yao L; Inagaki N; Franco A; Hata D; Maeda-Yamamoto M; Fukamachi H; Nagai H; Kawakami T
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2227-32. PubMed ID: 10051623
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors.
Wahl MI; Fluckiger AC; Kato RM; Park H; Witte ON; Rawlings DJ
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11526-33. PubMed ID: 9326643
[TBL] [Abstract][Full Text] [Related]
3. Defective degranulation and calcium mobilization of bone-marrow derived mast cells from Xid and Btk-deficient mice.
Setoguchi R; Kinashi T; Sagara H; Hirosawa K; Takatsu K
Immunol Lett; 1998 Dec; 64(2-3):109-18. PubMed ID: 9870661
[TBL] [Abstract][Full Text] [Related]
4. Functions of Bruton's tyrosine kinase in mast and B cells.
Kawakami Y; Kitaura J; Hata D; Yao L; Kawakami T
J Leukoc Biol; 1999 Mar; 65(3):286-90. PubMed ID: 10080529
[TBL] [Abstract][Full Text] [Related]
5. Involvement of Bruton's tyrosine kinase in FcepsilonRI-dependent mast cell degranulation and cytokine production.
Hata D; Kawakami Y; Inagaki N; Lantz CS; Kitamura T; Khan WN; Maeda-Yamamoto M; Miura T; Han W; Hartman SE; Yao L; Nagai H; Goldfeld AE; Alt FW; Galli SJ; Witte ON; Kawakami T
J Exp Med; 1998 Apr; 187(8):1235-47. PubMed ID: 9547335
[TBL] [Abstract][Full Text] [Related]
6. Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation.
Kawakami Y; Kitaura J; Satterthwaite AB; Kato RM; Asai K; Hartman SE; Maeda-Yamamoto M; Lowell CA; Rawlings DJ; Witte ON; Kawakami T
J Immunol; 2000 Aug; 165(3):1210-9. PubMed ID: 10903718
[TBL] [Abstract][Full Text] [Related]
7. Multiple signaling pathways for the activation of JNK in mast cells: involvement of Bruton's tyrosine kinase, protein kinase C, and JNK kinases, SEK1 and MKK7.
Kawakami Y; Hartman SE; Holland PM; Cooper JA; Kawakami T
J Immunol; 1998 Aug; 161(4):1795-802. PubMed ID: 9712046
[TBL] [Abstract][Full Text] [Related]
8. Bruton's tyrosine kinase-mediated interleukin-2 gene activation in mast cells. Dependence on the c-Jun N-terminal kinase activation pathway.
Hata D; Kitaura J; Hartman SE; Kawakami Y; Yokota T; Kawakami T
J Biol Chem; 1998 May; 273(18):10979-87. PubMed ID: 9556577
[TBL] [Abstract][Full Text] [Related]
9. PKCbeta modulates antigen receptor signaling via regulation of Btk membrane localization.
Kang SW; Wahl MI; Chu J; Kitaura J; Kawakami Y; Kato RM; Tabuchi R; Tarakhovsky A; Kawakami T; Turck CW; Witte ON; Rawlings DJ
EMBO J; 2001 Oct; 20(20):5692-702. PubMed ID: 11598012
[TBL] [Abstract][Full Text] [Related]
10. The phosphoinositide 3-kinase-dependent activation of Btk is required for optimal eicosanoid production and generation of reactive oxygen species in antigen-stimulated mast cells.
Kuehn HS; Swindle EJ; Kim MS; Beaven MA; Metcalfe DD; Gilfillan AM
J Immunol; 2008 Dec; 181(11):7706-12. PubMed ID: 19017959
[TBL] [Abstract][Full Text] [Related]
11. Absence of Tec family kinases interleukin-2 inducible T cell kinase (Itk) and Bruton's tyrosine kinase (Btk) severely impairs Fc epsilonRI-dependent mast cell responses.
Iyer AS; Morales JL; Huang W; Ojo F; Ning G; Wills E; Baines JD; August A
J Biol Chem; 2011 Mar; 286(11):9503-13. PubMed ID: 21212279
[TBL] [Abstract][Full Text] [Related]
12. RN486, a selective Bruton's tyrosine kinase inhibitor, abrogates immune hypersensitivity responses and arthritis in rodents.
Xu D; Kim Y; Postelnek J; Vu MD; Hu DQ; Liao C; Bradshaw M; Hsu J; Zhang J; Pashine A; Srinivasan D; Woods J; Levin A; O'Mahony A; Owens TD; Lou Y; Hill RJ; Narula S; DeMartino J; Fine JS
J Pharmacol Exp Ther; 2012 Apr; 341(1):90-103. PubMed ID: 22228807
[TBL] [Abstract][Full Text] [Related]
13. The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C.
Yao L; Kawakami Y; Kawakami T
Proc Natl Acad Sci U S A; 1994 Sep; 91(19):9175-9. PubMed ID: 7522330
[TBL] [Abstract][Full Text] [Related]
14. Pleckstrin homology domains interact with filamentous actin.
Yao L; Janmey P; Frigeri LG; Han W; Fujita J; Kawakami Y; Apgar JR; Kawakami T
J Biol Chem; 1999 Jul; 274(28):19752-61. PubMed ID: 10391917
[TBL] [Abstract][Full Text] [Related]
15. Btk plays a crucial role in the amplification of Fc epsilonRI-mediated mast cell activation by kit.
Iwaki S; Tkaczyk C; Satterthwaite AB; Halcomb K; Beaven MA; Metcalfe DD; Gilfillan AM
J Biol Chem; 2005 Dec; 280(48):40261-70. PubMed ID: 16176929
[TBL] [Abstract][Full Text] [Related]
16. Bruton's tyrosine kinase regulates apoptosis and JNK/SAPK kinase activity.
Kawakami Y; Miura T; Bissonnette R; Hata D; Khan WN; Kitamura T; Maeda-Yamamoto M; Hartman SE; Yao L; Alt FW; Kawakami T
Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3938-42. PubMed ID: 9108083
[TBL] [Abstract][Full Text] [Related]
17. Early and late events in Fc epsilon RI signal transduction in human cultured mast cells.
Suzuki H; Takei M; Yanagida M; Nakahata T; Kawakami T; Fukamachi H
J Immunol; 1997 Dec; 159(12):5881-8. PubMed ID: 9550384
[TBL] [Abstract][Full Text] [Related]
18. Bruton's tyrosine kinase is dispensable for the Toll-like receptor-mediated activation of mast cells.
Zorn CN; Keck S; Hendriks RW; Leitges M; Freudenberg MA; Huber M
Cell Signal; 2009 Jan; 21(1):79-86. PubMed ID: 18848985
[TBL] [Abstract][Full Text] [Related]
19. Silencing of Bruton's tyrosine kinase (Btk) using short interfering RNA duplexes (siRNA).
Heinonen JE; Smith CI; Nore BF
FEBS Lett; 2002 Sep; 527(1-3):274-8. PubMed ID: 12220673
[TBL] [Abstract][Full Text] [Related]
20. Bruton's Tyrosine Kinase inhibition by Acalabrutinib does not affect early or advanced atherosclerotic plaque size and morphology in Ldlr
Hemme E; Biskop D; Depuydt MAC; Smit V; Delfos L; Bernabé Kleijn MNA; Foks AC; Kuiper J; Bot I
Vascul Pharmacol; 2023 Jun; 150():107172. PubMed ID: 37075932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
